Monte Rosa Therapeutics, Inc. (GLUE)
SEC filings, insider trading & institutional ownership from EDGAR.
Latest filings
10-K, 10-Q, 8-K, Form 4 & 13D/G. Sourced directly from SEC EDGAR
No filings are available yet.
GLUE's filings are public. The insight is one click away.
Scrutar's AI reads every GLUE filing and surfaces what matters. Red flags, risk shifts, disclosure quality and key relationships. Cited to the source, free with an account.
Red Flag Detection20+ forensic checks per filingRisk RadarYear-over-year changes in risk factorsFiling DNADisclosure quality scored across six dimensionsSupply Chain GraphCustomers, suppliers & competitors mapped
Analyze GLUE filingsNo credit cardAI reports included on the free plan
Never miss a GLUE filing.
Get an email when GLUE files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Data as of Aug 29, 2026Source: SEC EDGAR.